03/08/2023
In honor of International Women’s Day, we want to introduce you to the woman behind BRT. Meet our co-founder, EVP, and wearer of all hats, Dr. Florence Burleson. 👏
Dr. Burleson received her PhD from the Department of Microbiology at the University of Notre Dame, and a Master of Science in Financial Management and Technology Commercialization from North Carolina State University. She has 30 years of professional experience in government, pharmaceutical, and contract research. She is the co-founder of BRT and has served as an immunotoxicology Study Director conducting GLP-compliant studies for immunological, functional, and host resistance immunotoxicity assessments.
She’s a member of the American College of Toxicology (ACT) and Society of Toxicology (SOT), and is currently President of ACT. She has served on the SOT Finance Committee and is past-President of the Immunotoxicology Specialty Section. She was the former Chair of the Scientific Liaison Coalition (SLC), a coalition of societies to increase the impact of the science of toxicology to improve public health. She currently serves on the Editorial Board of the International Journal of Toxicology, the official journal of ACT, and the Toxicology Research Application.
